References
- Hales C. N., Barker D. J. P. The thrifty phenotype hypothesis. Br Med Bull 2001; 60: 5–20
- Poulsen P., Vaag A. A., Kyvik K. O., Moller Jensen D., Beck‐Nielsen H. Low Birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs. Diabetologia 1997; 40: 439–46
- Barker D. J., Hales C. N., Fall C. H., Osmond C., Phipps K., Clark P. M. Type 2 (non‐insulin‐dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993; 36: 62–7
- Evans J. L., Goldfine I. D., Maddux B. A., Grodsky G. M. Are oxidative stress‐activated signaling pathways mediators of insulin resistance and beta‐cell dysfunction?. Diabetes 2003; 52: 1–8
- Ceriello A., Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004; 24: 816–23
- Mezzetti A., Cipollone F., Cuccurullo F. Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm. Cardiovasc Res 2000; 47: 475–88
- Shigenaga M. K., Gimeno C. J., Ames B. N. Urinary 8‐hydroxy‐2'‐deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci USA 1989; 86: 9697–701
- Dandona P., Thusu K., Cook S., Snyder B., Makowski J., Armstrong D., et al. Oxidative damage to DNA in diabetes mellitus. Lancet 1996; 347: 444–5
- Hinokio Y., Suzuki S., Hirai M., Suzuki C., Suzuki M., Toyota T. Urinary excretion of 8‐oxo‐7, 8‐dihydro‐2 '‐deoxyguanosine as a predictor of the development of diabetic nephropathy. Diabetologia 2002; 45: 877–82
- Jaquet D., Leger J., Levy‐Marchal C., Czernichow P. Low birth weight: effect on insulin sensitivity and lipid metabolism. Horm Res 2003; 59: 1–6
- Jaquet D., Czernichow P. Born small for gestational age: increased risk of type 2 diabetes, hypertension and hyperlipidaemia in adulthood. Horm Res 2003; 59: 131–7
- Jaquet D., Gaboriau A., Czernichow P., Levy‐Marchal C. Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. J Clin Endocrinol Metab 2000; 85: 1401–6
- Hermann T. S., Rask‐Madsen C., Ihlemann N., Dominguez H., Jensen C. B., Storgaard H., et al. Normal insulin‐stimulated endothelial function and impaired insulin‐stimulated muscle glucose uptake in young adults with low birth weight. J Clin Endocrinol Metab 2003; 88: 1252–7
- Ozanne S. E., Jensen C. B., Tingey K. J., Storgaard H., Madsbad S., Vaag A. A. Low birthweight is associated with specific changes in muscle insulin‐signalling protein expression. Diabetologia 2005; 48: 547–52
- Jensen C. B., Storgaard H., Dela F., Holst J. J., Madsbad S., Vaag A. A. Early differential defects of insulin secretion and action in 19‐year‐old Caucasian men who had low birth weight. Diabetes 2002; 51: 1271–80
- Paolisso G., Tataranni P. A., Foley J. E., Bogardus C., Howard B. V., Ravussin E. A high‐concentration of fasting plasma nonesterified fatty‐acids is a risk factor for the development of NIDDM. Diabetologia 1995; 38: 1213–7
- Paolisso G., Gambardella A., Tagliamonte M. R., Saccomanno F., Salvatore T., Gualdiero P., et al. Does free fatty acid infusion impair insulin action also through an increase in oxidative stress?. J Clin Endocrinol Metab 1996; 81: 4244–8
- Jensen C. B., Storgaard H., Holst J. J., Dela F., Madsbad S., Vaag A. A. Insulin secretion and cellular glucose metabolism after prolonged low‐grade intralipid infusion in young men. J Clin Endocrinol Metab 2003; 88: 2775–83
- Rasmussen E. L., Malis C., Jensen C. B., Jensen J. E., Storgaard H., Poulsen P., et al. Altered fat tissue distribution in young adult men who had low birth weight. Diabetes Care 2005; 28: 151–3
- Weimann A., Belling D., Poulsen H. E. Quantification of 8‐oxo‐guanine and guanine as the nucleobase, nucleoside and deoxynucleoside forms in human urine by high‐performance liquid chromatography‐electrospray tandem mass spectrometry. Nucl Acids Res 2002; 30: U48–U54
- Hillestrøm P. R., Hoberg A‐M., Weimann A., Poulsen H. E. Quantification of 1,N6‐Etheno‐2'‐deoxyadenosine in human urine by column‐switching LC/APCI‐MS/MS. Free Radic Biol Med 2004; 36: 1383–92
- Leinonen J., Lehtimaki T., Toyokuni S., Okada K., Tanaka T., Hiai H., et al. New biomarker evidence of oxidative dna damage in patients with non‐insulin‐dependent diabetes mellitus. FEBS Lett 1997; 417: 150–2
- Gæde P., Poulsen H. E., Parving H. H., Pedersen O. Double‐blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in type 2 diabetic patients. Diabet Med 2001; 18: 756–60
- Valdez R., Athens M. A., Thompson G. H., Bradshaw B. S., Stern M. P. Birth‐weight and adult health outcomes in a biethnic population in the USA. Diabetologia 1994; 37: 624–31
- Lithell H. O., McKeigue P. M., Berglund L., Mohsen R., Lithell U. B., Leon D. A. Relation of size at birth to non‐insulin dependent diabetes and insulin concentrations in men aged 50–60 years. Br Med J 1996; 312: 406–10
- McKeigue P. M., Lithell H. O., Leon D. A. Glucose tolerance and resistance to insulin‐stimulated glucose uptake in men aged 70 years in relation to size at birth. Diabetologia 1998; 41: 1133–8
- Ravelli A. C. J., van der Meulen J. H. P., Michels R. P. J., Osmond C., Barker D. J. P., Hales C. N., et al. Glucose tolerance in adults after prenatal exposure to famine. Lancet 1998; 351: 173–7
- Collins A. R., Raslova K., Somorovska M., Petrovska H., Ondrusova A., Vohnout B., et al. DNA damage in diabetes: correlation with a clinical marker. Free Radic Biol Med 1998; 25: 373–7
- Mastaloudis A., Morrow J. D., Hopkins D. W., Devaraj S., Traber M. G. Antioxidant supplementation prevents exercise‐induced lipid peroxidation, but not inflammation, in ultramarathon runners. Free Radic Biol Med 2004; 36: 1329–41